Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1984 1
1985 1
1987 1
1990 1
1991 2
1994 2
1995 1
1996 1
1997 4
1998 4
2000 2
2001 3
2002 3
2003 7
2004 2
2005 3
2006 4
2007 5
2008 7
2009 7
2010 5
2011 5
2012 5
2013 10
2014 10
2015 10
2016 10
2017 11
2018 12
2019 7
2020 9
2021 11
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 24088550

147 results

Results by year

Filters applied: . Clear all
Page 1
Giant prolactinomas in women.
Delgrange E, Raverot G, Bex M, Burman P, Decoudier B, Devuyst F, Feldt-Rasmussen U, Andersen M, Maiter D. Delgrange E, et al. Eur J Endocrinol. 2013 Nov 22;170(1):31-8. doi: 10.1530/EJE-13-0503. Print 2014 Jan. Eur J Endocrinol. 2013. PMID: 24088550 Review.
Giant prolactinomas: the therapeutic approach.
Moraes AB, Silva CM, Vieira Neto L, Gadelha MR. Moraes AB, et al. Clin Endocrinol (Oxf). 2013 Oct;79(4):447-56. doi: 10.1111/cen.12242. Epub 2013 Jun 11. Clin Endocrinol (Oxf). 2013. PMID: 23662975 Review.
Long-term outcome of multimodal therapy for giant prolactinomas.
Andujar-Plata P, Villar-Taibo R, Ballesteros-Pomar MD, Vidal-Casariego A, Pérez-Corral B, Cabezas-Agrícola JM, Álvarez-Vázquez P, Serramito R, Bernabeu I. Andujar-Plata P, et al. Endocrine. 2017 Jan;55(1):231-238. doi: 10.1007/s12020-016-1129-9. Epub 2016 Oct 4. Endocrine. 2017. PMID: 27704480
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients.
Vroonen L, Jaffrain-Rea ML, Petrossians P, Tamagno G, Chanson P, Vilar L, Borson-Chazot F, Naves LA, Brue T, Gatta B, Delemer B, Ciccarelli E, Beck-Peccoz P, Caron P, Daly AF, Beckers A. Vroonen L, et al. Eur J Endocrinol. 2012 Nov;167(5):651-62. doi: 10.1530/EJE-12-0236. Epub 2012 Aug 23. Eur J Endocrinol. 2012. PMID: 22918301 Free article.
Giant prolactinomas in men: efficacy of cabergoline treatment.
Corsello SM, Ubertini G, Altomare M, Lovicu RM, Migneco MG, Rota CA, Colosimo C. Corsello SM, et al. Clin Endocrinol (Oxf). 2003 May;58(5):662-70. doi: 10.1046/j.1365-2265.2003.01770.x. Clin Endocrinol (Oxf). 2003. PMID: 12699451
147 results